Three new ophthalmic devices gained FDA regulatory approval in 2011 and many important 501(k) clearances were granted.
Click to read FDA Approves Key Ophthalmic Devices in 2011 »
Posted by katiec on Wednesday 1 February, 2012 05:55 PM
Overall, IOL surgery climbed 2.5 percent in Q3-2011 with premium procedures again posting double-digit growth.
Click to read US IOL Procedures Climb by 2.5 Percent in Q3-2011»
Posted by daveharmon on Tuesday 20 December, 2011 03:00 PM
In 2011’s third quarter, total retinal procedure volume rose by more than 11 percent year over year, as IVT injections surged.
Click to read IVT Injections Continue to Drive US Retinal Procedures Higher in Q3-2011»
Posted by druthomas on Tuesday 20 December, 2011 03:00 PM
The global market in dry eye products will see steady, if modest, growth through 2016, much of which will be driven by aging, increased affluence, and access to health care in the developing world.
Click to read Dry Eye Products Market Positioned for Steady Growth»
Posted by daveharmon on Tuesday 20 December, 2011 03:00 PM
Regeneron/Bayer released integrated two-year results for Eylea in wet AMD in the VIEW studies. VA gains were mostly maintained, but a PRN protocol proved less effective than more regular dosing.
Click to read Regeneron & Bayer Release Eylea’s Two-Year Phase III Study Results »
Posted by druthomas on Tuesday 20 December, 2011 03:00 PM
This month's news includes the latest from Avedro, Bausch & Lomb, Laboratoria Pfortner Cornealent SACIF, Waicon, Regeneron, Bayer HealthCare, Alcon and NovaBay Pharmaceuticals.
Click to read December 2011 News Briefs»
Posted by All on Tuesday 20 December, 2011 03:00 PM
After three quarters with procedures inching higher, refractive surgery dips slightly.
Click to read Q3-2011 US Refractive Surgery Recedes Slightly»
Posted by daveharmon on Tuesday 22 November, 2011 01:21 PM
AAO Meeting Focuses on LRCS and Retina Meeting spotlights a wealth of topics.
Click to read Orlando AAO Highlights Laser Cataract Surgery & Retina Pharmaceuticals»
Posted by All on Tuesday 22 November, 2011 01:21 PM
Click to read FDA Approves Regeneron’s Eylea for US Market»
Posted by All on Tuesday 22 November, 2011 01:21 PM
Click to read FDA Effectively Denies Approval for Alimera’s Iluvien»
Posted by All on Tuesday 22 November, 2011 01:21 PM
Click to read Two Promising RP Technologies from Germany »
Posted by All on Tuesday 22 November, 2011 01:21 PM
Posted by All on Tuesday 22 November, 2011 01:21 PM
Minimally-invasive surgical technologies are set to boost the glaucoma device market.
Posted by wfreeman on Tuesday 22 November, 2011 01:21 PM
This month's news includes the latest from Staar Surgical, Iridex, Alcon, Synergetics and Bausch & Lomb.
Click to read November 2011 News Briefs»
Posted by All on Tuesday 22 November, 2011 01:21 PM
The AAO meeting in Orlando will shine a spotlight on laser refractive cataract surgery and Regeneron’s anti-VEGF fusion protein Eylea, among a wealth of other ophthalmic topics.
Click to read The 2011 AAO Promises Update on New Technologies & Techniques»
Posted by All on Tuesday 11 October, 2011 05:32 PM
Reports of severe eye infections following IVT Avastin injections in 21 AMD patients in three states have prompted the Veteran’s Administration to halt use of IVT Avastin pending a review. Repackaging of the cancer drug into IVT doses appears to be the culprit.
Click to read VA Temporarily Halts Use of IVT Avastin as Repackaging Triggers Safety Issues»
Posted by druthomas on Tuesday 11 October, 2011 05:32 PM
This month's news includes the latest from Santen, Carl Zeiss, IMEX and Bausch & Lomb.
Click to read October 2011 News Briefs»
Posted by All on Tuesday 11 October, 2011 05:32 PM
In Q2-2011 US cataract surgeries with premium IOLs grew at double digit rates as total IOL procedures kept pace with their long-term growth rates.
Click to read Premium IOL Procedures Climb to 14.8 Percent in Q2-2011 »
Posted by daveharmon on Wednesday 28 September, 2011 07:34 PM
The well-attended 2011 ESCRS meeting in Vienna saw a surprising number of new refractive and cataract equipment introductions and demonstrations.
Corneal Inlays
Excimer Laser
Laser-based Presbyopia Treatments
Femtosecond Flaps
Femtosecond Refractive Surgery
Corneal Cross Linking
Dizzying Array of IOLs
Presbyopia-correcting IOLs
Toric IOLs
Phakic IOLs
Laser Refractive Cataract Surgery
New Ultrasonic Phaco Machines
Glaucoma Surgery
Click to read New Product Introductions Abound at ESCRS Meeting»
Posted by David Harmon and William Freeman on Wednesday 28 September, 2011 07:34 PM
This month's news includes the latest from Bausch & Lomb, Technolas Perfect Vision GmbH, Optimedica, VisionCare Ophthalmic, Avedro and the latest report from the Inspector General of the US Department of Health and Human Services.
Click to read September 2011 News Briefs»
Posted by All on Wednesday 28 September, 2011 07:34 PM
US refractive procedure volume rose in Q2-2011 but failed to meet expectations, paralleling continued weakness in the US economy and spurring a downward revision of our forecast.
Click to read US Refractive Surgery Market Still Sputtering»
Posted by daveharmon on Thursday 25 August, 2011 02:34 PM
Q2-2011’s survey of retina specialists indicates a slowing of the significant growth in IVT injections that has been experienced in recent quarters. Vitrectomy numbers edged up, while laser photocoagulation and PDT procedures further declined.
Click to read Increases in US IVT Injections Slowed in Q2-2011»
Posted by druthomas on Thursday 25 August, 2011 02:34 PM
Click to read FDA Decision on Eylea (VEGF Trap-Eye) Postponed»
Posted by All on Thursday 25 August, 2011 02:34 PM
More than 470 ophthalmic diagnostic products are expected to generate $2.3 billion in revenue this year. Our 2011 Comprehensive Report on the Global Ophthalmic Diagnostic Equipment Market will be released by the end of the summer.
Click to read 2011 Ophthalmic Diagnostic Equipment Market Expected to Reach $2.3 Billion»
Posted by daveharmon on Thursday 25 August, 2011 02:34 PM
IOL companies are currently trying to reinvigorate the new technology IOL (NTIOL) designation based on several claims.
Click to read IOL Companies Hope to Reclaim US NTIOL Status»
Posted by wfreeman on Thursday 25 August, 2011 02:34 PM
This month's news includes the latest from PowerVision, Abbott Medical Optics, ISTA Pharmaceuticals, Merge Healthcare and Ophthalmic Imaging Systems.
Click to read August 2011 News Briefs»
Posted by All on Thursday 25 August, 2011 02:34 PM
New ophthalmic diagnostic technologies are advancing care, particularly when they work in synergy with new treatment paradigms.
Posted by daveharmon on Monday 25 July, 2011 03:44 PM
This market will be buoyed by increasing ophthalmic surgical procedures worldwide and fear of cross-contamination, but growth in some segments will be constrained by greater use of micro-surgical techniques.
Click to read Modest Growth Forecast for the Single-Use Ophthalmic Surgical Device Market»
Posted by wfreeman on Monday 25 July, 2011 03:44 PM
Many of the NHS’s PCTs have raised the visual acuity threshold for cataract surgery in an effort to control costs, denying or delaying surgery for thousands of UK residents.
Click to read UK Takes Steps to Ration Cataract Surgery by Changing Visual Acuity Thresholds»
Posted by wfreeman on Monday 25 July, 2011 03:44 PM
The FDA granted few regulatory approvals to ophthalmic devices during the past eight months. Review times increased nearly 60 percent from 2005 to 2010.
Click to read Few FDA Regulatory Approvals for Ophthalmic Devices »
Posted by daveharmon on Monday 25 July, 2011 03:44 PM
Generics and labeling changes have dominated FDA regulatory approvals for ophthalmic drugs thus far in 2011, but many await the likely approval of Eylea (VEGF Trap-Eye) later this year.
Posted by druthomas on Monday 25 July, 2011 03:44 PM
This month's news includes the latest from Transcend Medical, SARcode Bioscience, Ivantis, MicroLabs and Bausch & Lomb.
Click to read July 2011 News Briefs»
Posted by All on Monday 25 July, 2011 03:44 PM
The FDA advisory panel recommended approval of Regeneron’s VEGF Trap-Eye for wet AMD. The fusion protein is likely to become a serious challenger to Genentech’s Lucentis and off-label IVT Avastin.
Posted by druthomas on Sunday 26 June, 2011 03:55 PM
Premium IOL procedures approached 15 percent of all US IOL procedures during Q1-2011.
Click to read US Premium IOL Procedures Climb in Q1-2011»
Posted by daveharmon on Sunday 26 June, 2011 03:55 PM
In Q1-2011, refractive surgeries showed rather anemic improvement, as the consumer confidence index again dipped during this protracted recession.
Click to read Refractive Surgery Shows Weak Improvement in Q1-2011»
Posted by daveharmon on Sunday 26 June, 2011 03:55 PM
Is LASIK yesterday’s technology or is it poised for recovery? Both arguments raise valid issues.
Click to read Is LASIK Yesterday’s Technology or is it Poised for Recovery?»
Posted by daveharmon on Sunday 26 June, 2011 03:55 PM
Our new 2011 Comprehensive Report on the Global Cataract Equipment Market forecasts the five-year impact of laser refractive cataract surgery in wealthier nations and the conversion to ultrasonic phaco in emerging markets.
Click to read Laser Refractive Cataract Surgery to Expand Cataract Equipment Market»
Posted by wfreeman on Sunday 26 June, 2011 03:55 PM
This month's news includes the latest from CROMA, Bausch & Lomb, Merge Healthcare, Ophthalmic Imaging Systems, Alcon, NovaBay Pharmaceuticals, Pfizer and pSivida.
Click to read June 2011 News Briefs»
Posted by All on Sunday 26 June, 2011 03:55 PM
The number of IVT injections in the US continued to climb, as Avastin’s share declined somewhat and Lucentis’ share increased.
Click to read US Market for Retina Treatments Continues to Grow Due to Increased Use of Anti-VEGFs»
Posted by daveharmon on Monday 23 May, 2011 07:53 PM
The Association of Research in Vision and Ophthalmology (ARVO) offered a window on cutting edge eye science and medicine plus clinical trials updates for retinal agents.
CATT, Lucentis & Avastin
VEGF Trap-Eye
Other AMD & DME Clinical Trials
Investigational Glaucoma Therapies
Dry AMD
Genetics & Genomics
Nanotechnology & Regenerative Medicine
Posted by druthomas on Monday 23 May, 2011 07:53 PM
Click to read Investigational Glaucoma Pharmaceuticals at ARVO»
Posted by druthomas on Monday 23 May, 2011 07:53 PM
Click to read Market Scope Introduces New Online Survey Application»
Posted by daveharmon on Monday 23 May, 2011 07:53 PM
Our new 2011 Comprehensive Report on the Global IOL Market forecasts significant revenue growth in the next five years.
Click to read Annual Global IOL Revenue Growth Forecast at 7.6 Percent through 2016»
Posted by wfreeman on Monday 23 May, 2011 07:53 PM
Click to read May 2011 News Briefs»
Posted by katiec on Monday 23 May, 2011 07:53 PM
The ASCRS meeting was abuzz with interest in laser refractive cataract surgery (LRCS). IOLs, alternative presbyopia surgical technologies, and new glaucoma surgical devices also garnered attention. This article covers the following ASCRS topics:
Laser Refractive Cataract Surgery
Presbyopia Correction
Other IOLs
Corneal Inlays
Other Presbyopia Techniques
Femtosecond Refractive Surgery
Excimer Lasers
Corneal Crosslinking
Glaucoma Day
Click to read Laser Refractive Cataract Surgery Headlines ASCRS Meeting»
Posted by David Harmon and William Freeman on Wednesday 13 April, 2011 02:41 PM
Our new 2011 Comprehensive Report on the Global Presbyopia Market forecasts significant growth in the next five years.
Click to read Presbyopia Surgery Market Poised for Rapid Growth»
Posted by daveharmon on Wednesday 13 April, 2011 02:41 PM
Rigorous FDA investigation of LASIK falls short in serving the public, doctors, and industry.
Click to read ASCRS FDA Session on LASIK Underscores the Agency’s Disconnect with Reality»
Posted by daveharmon on Wednesday 13 April, 2011 02:41 PM
Scientists, glaucoma specialists, and start-up company executives discussed the potential for new minimally-invasive glaucoma surgical devices at the third annual Cutting Edge meeting held before the American Glaucoma Society convention.
Click to read Cutting Edge 3 Meeting Explores New Minimally-Invasive Glaucoma Surgery Devices»
Posted by wfreeman on Wednesday 13 April, 2011 02:41 PM
This month's news includes the latest from Merck, Inspire Pharmaceuticals, Alcon, Bausch & Lomb and Technolas Perfect Vision.
Click to read April 2011 News Briefs»
Posted by All on Wednesday 13 April, 2011 02:41 PM
The rate of growth in cataract surgery matched expectations in Q4-2010 after the disruptions to the normal growth patterns earlier in 2010.
Click to read Cataract Surgery Growth Rate Matches Expectations at 3.2 Percent in Q4-2010 »
Posted by daveharmon on Monday 14 March, 2011 08:46 PM
The upcoming ASCRS meeting focuses much attention on PC-IOLs, the promise of the new laser refractive cataract surgery, corneal inlays, and new glaucoma surgical devices. We preview the meeting in this issue and offer a clip-out page of sessions to look for when you arrive at the meeting.
Presbyopia-Correcting IOLs
Surgical Treatment of Astigmatism
Phakic IOLs
Advances in Cataract Surgery
Advances in glaucoma surgery
Excimer laser refractive surgery
Corneal inlays & scleral implants
Dry eye
Femtosecond refractive surgery
IntraCor intrastromal ablation
Corneal crosslinking
Click to read ASCRS Meeting Promises the Latest on Technologies that Promise to Change the Industry»
Posted by All on Monday 14 March, 2011 08:46 PM
Click to read March 2011 News Briefs»
Posted by All on Monday 14 March, 2011 08:46 PM
The US refractive surgery market showed signs of improvement in Q4-2010, though the unemployment rate is expected to constrain the rate of growth through the balance of 2011. Nonetheless, Market Scope has raised its 2011 forecast.
Click to read Q4-2010 US Refractive Surgery Up 7.5 Percent »
Posted by daveharmon on Monday 28 February, 2011 12:50 PM
In Q4-2010, IVT injections continued to climb as laser photocoagulation procedures slipped and PDT procedures dropped precipitously. Vitrectomies fell very slightly during the quarter.
Click to read Q4-2010 IVT Injections Increase 10.5 Percent Over Q4-2009 Tallies»
Posted by druthomas on Monday 28 February, 2011 12:50 PM
As the difficult economic period for laser vision correction begins to abate, we offer capsule profiles of seven of the leading global corporate laser centers.
Click to read Corporate Laser Centers Search for Success in Challenging Markets»
Posted by daveharmon on Monday 28 February, 2011 12:50 PM
We expect newer devices entering the market beginning in 2011 to fuel yearly global revenue growth of 9 percent in the retinal surgical device market.
Click to read Newer Devices Will Drive Future Revenue Growth in the Retinal Surgical Device Market »
Posted by wfreeman on Monday 28 February, 2011 12:50 PM
This month's news news briefs include news from Aquesys, Regeneron, Bayer Healthcare, Genentech, Bausch + Lomb and SarCode Corporation.
Click to read February 2011 News Briefs»
Posted by All on Monday 28 February, 2011 12:50 PM
In 2010, the refractive market remained under pressure in the US and other wealthy nations due to weakened economic conditions, but growing demand in emerging economies more than offset these declines.
Click to read Emerging Markets Drive 2010 Refractive Market Growth »
Posted by daveharmon on Monday 24 January, 2011 08:49 PM
Demand for PC-IOLs and other special purpose IOLs drove growth in the IOL industry during 2010.
Click to read Growth in IOL Industry Driven by Premium Special-Purpose Lenses in 2010»
Posted by wfreeman on Monday 24 January, 2011 08:49 PM
2010 saw rapid growth in the number of intravitreal injections, but the soaring volume magnified questions about the risks, the costs, and the sustainability of the trend.
Click to read 2010 IVT Injections Soar and Raise Troubling Questions »
Posted by druthomas on Monday 24 January, 2011 08:49 PM
In 2010, seven ophthalmic devices achieved FDA regulatory approval and four important 510(k) clearances were granted.
Click to read New Ophthalmic Devices Get FDA Nod in 2010»
Posted by David Harmon and William Freeman on Monday 24 January, 2011 08:49 PM
The FDA approved seven ophthalmic drugs for commercialization in the US.
Click to read FDA Approves Seven Ophthalmic Drugs in 2010»
Posted by druthomas on Monday 24 January, 2011 08:49 PM
Eleven ophthalmic firms developing products received venture-capital infusions during 2010.
Click to read Despite the Economy, 2010 Was a Big Year for Funding Ophthalmic Ventures»
Posted by daveharmon on Monday 24 January, 2011 08:49 PM
This month's news briefs include news from Alimera Sciences, Alcon, Novartis, Bausch & Lomb, TrueVision 3D Surgical, Advanced Cell Technology, Inc., and New Leaf Venture Partners.
Click to read January 2011 News Briefs»
Posted by All on Monday 24 January, 2011 08:49 PM
In the ongoing saga of the flawed Medicare SGR formula, another extension is on the horizon—this time for 12 months.
Click to read SGR Crisis Triggers Yet Another Fix»
Posted by daveharmon on Wednesday 15 December, 2010 07:25 PM
NTIOL designations for IOLs with aspheric optics are set to expire in February, along with their added $50 ASC reimbursement.
Click to read NTIOL Provision Set to Expire in February of 2011»
Posted by wfreeman on Wednesday 15 December, 2010 07:25 PM
As the US faces temporary congressional fixes for scheduled cuts in Medicare reimbursements, cataract surgeons in other countries are also coping with cuts in reimbursements.
Click to read Declines in Cataract Surgery Reimbursements are Felt Worldwide»
Posted by wfreeman on Wednesday 15 December, 2010 07:25 PM
Genentech continues to invite controversy with a secret rebate program, as attention to the price disparity between IVT Avastin and Lucentis raises questions about the costs of efficacy.
Click to read Genentech’s Actions Continue to Spark Controversy»
Posted by druthomas on Wednesday 15 December, 2010 07:25 PM
Driven by disposable products, compounded annual growth in the surgical instruments market is forecast at 5.1 percent through 2015.
Click to read Disposable Instruments will Fuel Global Market Growth in Surgical Instruments »
Posted by wfreeman on Wednesday 15 December, 2010 07:25 PM
Emerging markets will lead compounded annual 7.1 percent growth in the global refractive surgery market during the next five years.
Click to read Emerging Markets Drive Growth in Refractive Surgery»
Posted by daveharmon on Wednesday 15 December, 2010 07:25 PM
Click to read December 2010 News Briefs»
Posted by All on Wednesday 15 December, 2010 07:25 PM
Increases in US cataract surgery lagged expectations during the third quarter of 2010, as cataract surgeons and patients alike were stymied by uncertainty over the SGR formula for Medicare reimbursement cuts and failure of the US Congress to address the matter with anything more than short-term postponements.
Click to read Growth Rates for US IOL Procedures Lag Expectations at 1.6 Percent in Q3-2010»
Posted by katiec on Tuesday 23 November, 2010 08:01 PM
Refractive surgery volume continues its slide at 6.4 percent during 2010’s third quarter, but 18 percent of survey respondents report an increase in volume.
Click to read Q3-2010 US Refractive Surgery Falls Another 6.4 Percent »
Posted by katiec on Tuesday 23 November, 2010 07:40 PM
Rapidly increasing IVT injection volume drove better than 10 percent growth in all retinal procedures during Q3-2010, while PDT and laser photocoagulation procedures declined and vitrectomy numbers held steady.
Click to read IVT Injections of Anti-VEGFs Continue to Drive Increases in Retinal Procedure Volume »
Posted by katiec on Tuesday 23 November, 2010 07:17 PM
This month's news briefs include news from Bayer HealthCare, Regeneron Pharmaceuticals, Avedro, Bausch + Lomb and also updates the status of the temporary postponement of the cuts in phyiscian reimbursements that are scheduled to take effect on December 1.
Click to read November 2010 News Briefs»
Posted by katiec on Tuesday 23 November, 2010 06:01 PM
This year’s meeting was particularly busy with cataract/IOL and retina topics. We review some of the hottest topics and most pivotal sessions in IOLs and cataract surgery, refractive surgery, retinal pharmaceuticals and biotech, retinal surgery, and glaucoma. We also offer six of the meeting's top themes, as well as several short pieces gleaned from this year’s AAO meeting: "Turbulent Times in the Ophthalmic Industry," "Two Retinal Prostheses Readying to Enter Europe’s Market," and "Retinopathy of Prematurity on the Rise."
Click to read AAO Chalks Up Successful 2010 Meeting»
Posted by All on Monday 8 November, 2010 01:08 PM
AAO sessions offered ample exploration of presbyopia-correcting and phakic IOLs and of cataract surgical techniques, and the new laser refractive cataract surgery technology was one of the hottest topics at the meeting.
Click to read 2010 AAO - IOLS & CATARACT SURGERY»
Posted by All on Monday 8 November, 2010 01:08 PM
Refractive surgery was a common topic at the AAO with a two-day long subspecialty session kicking off the meeting and several symposia dedicated to related topics such as presbyopia. Papers focused on new refractive laser development efforts and corneal inlays were especially popular subjects. In addition, new excimer lasers and flap makers from Alcon and Schwind attracted much attention on the exhibit floor.
Click to read 2010 AAO - REFRACTIVE SURGERY»
Posted by All on Monday 8 November, 2010 01:08 PM
“It was the best of times, it was the worst of times. It was an age of wisdom, it was an age of foolishness...” Late in Friday’s Subspecialty Day program, Scott Cousins, MD, used the famous opening line from Dickens’ A Tale of Two Cities as an apt characterization of the current environment in retinal medicine.
Click to read 2010 AAO-RETINAL PHARMA & BIOTECH»
Posted by All on Monday 8 November, 2010 01:08 PM
Retinal surgery topics included micro-incision vitreoretinal surgery with 23-gauge and 25-gauge instruments, the shift of more retinal surgeries to ASCs and the possibilities of in-office surgeries, and the introduction of a new combination vitrectomy/cataract system designed to take advantage of increasing ASC use in the retinal subspecialty.
Click to read 2010 AAO - RETINAL SURGERY»
Posted by All on Monday 8 November, 2010 01:08 PM
Glaucoma's one day subspecialty program revisited the debate about filtering surgeries vs. shunts and spent limited time on new drainage devices and investigational pharmaceuticals.
Click to read 2010 AAO - Glaucoma»
Posted by All on Monday 8 November, 2010 01:08 PM
Daunting challenges face the ophthalmic industry that promise to change the landscape significantly for most participants: ophthalmologists, manufacturers, scientists/researchers, and patients.
Click to read Turbulent Times for Ophthalmologists and the Industry Were Apparent at the AAO»
Posted by daveharmon on Monday 8 November, 2010 01:08 PM
At least 23 research teams are currently working on retinal prosthesis projects in various parts of the world, and two of these projects are nearing key regulatory approvals and ultimate commercialization.
Click to read Two Retinal Prostheses May Enter Europe’s Market Within Little More than a Year»
Posted by druthomas on Monday 8 November, 2010 01:08 PM
Retinopathy of prematurity is increasing both in the US and elsewhere in the world. Anti-VEGFs are showing some success in addressing this phenomenon.
Click to read Retinopathy of Prematurity on the Rise»
Posted by druthomas on Monday 8 November, 2010 01:08 PM
The summit, which immediately preceded the AAO, spotlighted development-stage ophthalmic companies. Venture capital firms, ophthalmologists, and consultants attended.
Posted by daveharmon on Monday 8 November, 2010 01:08 PM
The advent of current anti-VEGF treatments has spurred dramatic growth and huge wave of pipeline agents. Our updated report on the market is now available.
Click to read Annual Retinal Pharmaceutical Market Expected to Grow at 8.3 Percent Through 2015»
Posted by daveharmon on Monday 8 November, 2010 01:08 PM
This month's news briefs include news from TLC Vision, LCA-Vision, Heidelberg Engineering and Bausch + Lomb.
Click to read November 2010 News Briefs»
Posted by All on Monday 8 November, 2010 01:08 PM
Q2-2010 retina procedures increased by more than 14 percent from Q2-2009, while IVT injections rose by 23 percent.
Click to read IVT Injections Increased by 23 Percent During 2010's Second Quarter»
Posted by daveharmon on Thursday 7 October, 2010 05:27 PM
This year’s meeting features an agenda particularly busy with cataract/IOL and retina topics and evidencing the blurring lines between cataract surgeons and refractive surgeons.
Click to read What's Coming Up at the AAO?»
Posted by All on Thursday 7 October, 2010 05:27 PM
(巨大的亞洲會議在京眼)
The Beijing meeting included session topics ranging from treatments with traditional Chinese medicine to the latest cutting edge technologies.
Click to read APAO & COS Hold Joint Meeting in Beijing»
Posted by daveharmon on Thursday 7 October, 2010 05:27 PM
Click to read China Offers Significant Market Opportunity in Ophthalmology in the Coming Decade »
Posted by daveharmon on Thursday 7 October, 2010 05:27 PM
Former FDA panel member challenges LASIK’s safety and the ASCRS Ectasia Registry.
Click to read LASIK Safety Questions Fueled by One-time FDA Panel Leader»
Posted by daveharmon on Thursday 7 October, 2010 05:27 PM
Innovative glaucoma drainage devices are expected to stimulate demand in the glaucoma surgical device market through 2015.
Click to read Glaucoma Surgery Options To Grow Over Next Five Years»
Posted by wfreeman on Thursday 7 October, 2010 05:27 PM
This month's news briefs include news from Abbott, Alcon, Novartis, Topcon, oculentis, Burkl, and Bausch & Lomb.
Click to read October 2010 News Briefs»
Posted by All on Thursday 7 October, 2010 05:27 PM
After two quarters of record increases, the growth rate for US cataract surgeries slowed in Q2-2010.
Click to read Q2-2010 US IOL Growth Rate Slows to 1.1 Percent»
Posted by daveharmon on Tuesday 28 September, 2010 01:03 PM
The US refractive surgery market continued its decline in Q2-2010, but the decrease was much smaller than in 2008 and 2009.
Click to read Q2-2010 Refractive Surgery Slips Another 3.9 Percent»
Posted by daveharmon on Tuesday 28 September, 2010 01:03 PM
The ESCRS meeting in Paris featured new lasers and much discussion of laser refractive cataract surgery, along with a busy agenda of premium IOL presentations, cautionary tales about prophylactic use of anti-infectives, and much, much more.
Click to read ESCRS Meeting Showcases New Lasers and Premium IOLs»
Posted by daveharmon on Tuesday 28 September, 2010 01:03 PM
Modest growth forecast through 2015 for single-use ophthalmic surgical products.
Click to read Modest Growth Forecast for the Single-Use Ophthalmic Surgical Device Market»
Posted by wfreeman on Tuesday 28 September, 2010 01:03 PM
Click to read Alcon Completes LenSx Acquisition»
Posted by daveharmon on Tuesday 28 September, 2010 01:03 PM
Dry eye market forecast to grow at a CAGR of 7.8 percent through 2015.
Click to read Global Dry Eye Market Expected to Grow at a Rate of 7.8 Percent Through 2015»
Posted by daveharmon on Tuesday 28 September, 2010 01:03 PM
Glaukos iStent nears the finish line in gaining FDA regulatory approval.
Click to read Ophthalmic Device Panel Recommends Approval for Glaukos Glaucoma Stent»
Posted by daveharmon on Tuesday 28 September, 2010 01:03 PM
New combination cataract-vitrectomy system is now available to retinal surgeons.
Click to read Bausch + Lomb Launches Stellaris PC»
Posted by wfreeman on Tuesday 28 September, 2010 01:03 PM
Impressive clinical trial results win another label indication for Lucentis.
Click to read Lucentis Gains FDA Approval for Treatment of RVO»
Posted by druthomas on Tuesday 28 September, 2010 01:03 PM
Development program for Investigational dry eye pharmaceutical ends and Inspire's amends agreement with Allergan.
Click to read Inspire Halts Prolacria Development»
Posted by druthomas on Tuesday 28 September, 2010 01:03 PM
Click to read September 2010 News Briefs»
Posted by All on Tuesday 28 September, 2010 01:03 PM
The much-anticipated laser refractive cataract surgery technology is poised to launch this year and has unleashed a bloggers’ stream of pros and cons.
Click to read Expectations for Laser Refractive Cataract Surgery»
Posted by wfreeman on Monday 19 July, 2010 01:51 PM
IVT injections and vitrectomy volume increased in Q1-2010, as laser photocoaguation and PDT declined.
Click to read Market for Retina Products Increasingly Complex»
Posted by daveharmon on Monday 19 July, 2010 01:51 PM
Alcon has announced purchase plans for LenSx Lasers and its femtosecond LRCS technology.
Click to read Alcon to Acquire LenSx Lasers»
Posted by wfreeman on Monday 19 July, 2010 01:51 PM
After a long wait, the device for end-stage AMD gains pre-market clearance.
Posted by daveharmon on Monday 19 July, 2010 01:51 PM
Greater health care access in the developing world and the new LRCS technology will spur market growth.
Posted by wfreeman on Monday 19 July, 2010 01:51 PM
Demographic shifts as well as economic pressures may be affecting the LASIK market .
Click to read LASIK Patient Demographics Are Shifting»
Posted by daveharmon on Monday 19 July, 2010 01:51 PM
Alcon’s independent directors get a war chest and a favorable Swiss legal opinion.
Click to read Alcon's Independent Directors Could Foil Terms of Novartis' Merger Plan»
Posted by druthomas on Monday 19 July, 2010 01:51 PM
This month's news briefs include news from the US Congress, Genentech, pSivida Corp., Alimera Sciences, and Glaukos.
Click to read July 2010 News Briefs»
Posted by All on Monday 19 July, 2010 01:51 PM
US IOL procedures volume rose a significant 4.6 percent in Q1-2010 over Q1-2009's total.
Click to read Q1-2010 US IOL Procedures Climb 4.6 Percent»
Posted by daveanddru on Tuesday 22 June, 2010 12:31 PM
RoundTable Healthcare will acquire BD Ophthalmic Systems and several product platforms from Becton Dickinson.
Click to read RoundTable Healthcare Partners to Acquire BD Ophthalmic Systems»
Posted by wfreeman on Tuesday 22 June, 2010 12:31 PM
Bausch & Lomb launches a new combo phaco and vitrectomy system.
Click to read Bausch & Lomb Launches Stellaris PC Vision Enhancement System»
Posted by wfreeman on Tuesday 22 June, 2010 12:31 PM
Femtosecond lasers have become the standard of care for LASIK in the US, while their use expands elsewhere in the world and new applications are found.
Click to read Femtosecond Lasers Evolve to Standard of Care for LASIK in the US»
Posted by daveanddru on Tuesday 22 June, 2010 12:31 PM
New competitors in the US IOL market are likely to challenge the market leaders in the years ahead.
Click to read Newcomers to US IOL Market Pose a Future Challenge to Market Leaders’ Dominance»
Posted by wfreeman on Tuesday 22 June, 2010 12:31 PM
We expect IOL unit sales to reach about 19.3 million worldwide in 2010, generating revenues of about $2.27 billion.
Click to read Annual Global IOL Market Growth of 8.1 Percent Forecast Through 2015»
Posted by wfreeman on Tuesday 22 June, 2010 12:31 PM
This month's news briefs include news from LensAR, Bausch & Lomb, Sirion Therapeutics, QLT, Thrombogenics, and TLC Vision.
Click to read June 2010 News Briefs»
Posted by All on Tuesday 22 June, 2010 12:31 PM
US laser refractive surgery volume declined 0.9 percent from Q1-2009 to Q1-2010, a much smaller decline than in the previous eight quarters and an early sign that recovery may be beginning.
Click to read Q1-2010 Refractive Surgery Slips Only 1.5 Percent»
Posted by daveanddru on Tuesday 18 May, 2010 12:40 PM
ARVO’s 2010 annual meeting returned to Fort Lauderdale, FL earlier this month. In this edition, we report on a selection of presentations at this international meeting that highlights scientific research into vision and ophthalmic disease. See also several short online articles from ARVO accompanying this coverage.
Posted by druthomas on Tuesday 18 May, 2010 12:40 PM
Researchers found a significant association between nicotine use and a failure to respond to VEGF inhibition.
Click to read 2010 ARVO Meeting: Nicotine and Anti-VEGF Therapy»
Posted by druthomas on Tuesday 18 May, 2010 12:40 PM
During the ARVO meeting, two-year results were announced for the DRCR Network's DME clinical trial evaluating treatment with Lucentis, Triamcinolone, and laser photocoaguation.
Click to read 2010 ARVO Meeting: Laser/Lucentis/Triamcinolone Clinical Trial for DME»
Posted by druthomas on Tuesday 18 May, 2010 12:40 PM
Glaucoma was a topic of many ARVO sessions. Two of the many approaches to treatment discussed at the meeting were Rho-kinase inhibition and early animal studies in optic nerve regeneration.
Click to read 2010 ARVO Meeting: Research on Glaucoma Therapies»
Posted by druthomas on Tuesday 18 May, 2010 12:40 PM
US Congressional actions challenge Medicare pay for doctors in these difficult times.
Click to read Another Short-Term Reprieve Extends US Medicare Uncertainty»
Posted by daveanddru on Tuesday 18 May, 2010 12:40 PM
Newer retinal surgical device technologies to drive global market growth at a CAGR of more than 8 percent over the next five years.
Click to read Newer Retinal Surgical Devices Will Drive Future Revenue Growth»
Posted by wfreeman on Tuesday 18 May, 2010 12:40 PM
Ophthalmologists and industry participants from all over the world are expected to attend the 32nd World Ophthalmology Congress (WOC) in Berlin on June 5 thru 9.
Click to read 2010 World Ophthalmology Congress (WOC) Meets Next Month in Berlin»
Posted by wfreeman on Tuesday 18 May, 2010 12:40 PM
This month's issue includes the latest news from Alcon, TLC Vision and Genentech Roche.
Click to read May 2010 News Briefs»
Posted by All on Tuesday 18 May, 2010 12:40 PM
The 2010 ASCRS meeting in Boston broke attendance records. In this edition we report on the wealth of information at the meeting.
Click to read 2010 ASCRS Meeting Attracts Record-Breaking Crowd »
Posted by David Harmon and William Freeman on Tuesday 27 April, 2010 03:58 PM
Significant interest in the premium IOL market and the promise of the new femtosecond laser-assisted cataract surgery generated large crowds at many sessions of this year’s ASCRS meeting. Cataract and IOL-related topics were many and varied.
Posted by wfreeman on Tuesday 27 April, 2010 03:58 PM
Increased use of SLT, new glaucoma drainage devices, and issues associated with cataract surgery in patients with glaucoma drew a sizable crowd to the ASCRS' Glaucoma Day program.
Posted by wfreeman on Tuesday 27 April, 2010 03:58 PM
Femtosecond technology, corneal inlays, multifocal ablations, and corneal crosslinking were among the topics that garnered the attention of refractive surgeons at the meeting.
Posted by daveanddru on Tuesday 27 April, 2010 03:58 PM
ArcScan demonstrated its new Artemis ultrasound and Sensomotoric Instruments showed their new Surgery Guidance System. The ORange intraoperative aberrometer generated much interest at WaveTec Vision Systems' booth on the exhibit floor.
Click to read 2010 ASCRS Meeting: Special Report on Diagnostic Equipment at the 2010 ASCRS»
Posted by daveanddru on Tuesday 27 April, 2010 03:58 PM
Market Scope expects the young market of varied presbyopia surgery technologies to grow nearly 10 fold by 2020.
Posted by daveanddru on Tuesday 27 April, 2010 03:58 PM
This month's issue includes the latest news from Alimera Sciences, Thrombogenics, Bausch & Lomb, Santen Pharmaceuticals, Novagali, and Sanofi-Aventis.
Click to read April 2010 News Briefs»
Posted by All on Tuesday 27 April, 2010 03:58 PM
In Q4-2009, IOL procedure volume climbed 4.7 percent and demand for PC-IOLs rose to 6.7 percent of IOL procedures as patients returned to their doctors for the procedures many may have previously postponed.
Click to read Q4-2009 IOL Procedures Soar 4.7 Percent»
Posted by daveanddru on Monday 15 March, 2010 05:28 PM
The upcoming ASCRS meeting promises a wealth of informative sessions and highlights the increasing overlap in cataract and refractive surgeries. Glaucoma, too, gets close scrutiny. We preview the meeting in this issue and offer a page of sessions to look for when you arrive at the meeting. Topics include:
Click to read Upcoming ASCRS Brings the Merging of Cataract and Refractive Specialties into Focus»
Posted by David Harmon and William Freeman on Monday 15 March, 2010 05:28 PM
Femtosecond laser-assisted cataract surgery received much attention at Aspen’s Invitational Refractive Symposium.
Click to read Femtosecond Laser-Assisted Cataract Surgery Debated at AIRS Meeting»
Posted by daveanddru on Monday 15 March, 2010 05:28 PM
This month's news includes the latest from Bausch & Lomb, NicOx S.A., Staar Surgical, Domilens GmbH, and Abbott Medical Optics.
Click to read March 2010 News Briefs»
Posted by All on Monday 15 March, 2010 05:28 PM
Refractive surgery volumes continued their decline as demand for the procedures fell out of step with US consumer confidence measures.
Click to read Q4-2009 Refractive Surgery Down 10.5 Percent»
Posted by daveanddru on Tuesday 16 February, 2010 01:19 PM
During this severe and long-lasting recession, corporate laser centers have been particularly hard hit as many have faced drastic cost cutting, laser center closings, and bankruptcy.
Click to read Economic Distress Takes a Toll on Corporate Laser Refractive Business»
Posted by daveanddru on Tuesday 16 February, 2010 01:19 PM
An aging population and accelerating increases in cases of diabetic retinopathy are causing the number of retinal IVT injections to soar, while improved surgical techniques and technology have combined with these factors to drive increases in vitrectomy procedures.
Click to read The Latest Techniques & Technologies Spark New Retinal Treatment Realities»
Posted by daveanddru on Tuesday 16 February, 2010 01:19 PM
Alcon’s recent asset acquisitions from Sirion Therapeutics are the latest in an abundance of acquisitions, licensing agreements and collaborations in the ophthalmic pharmaceutical industry.
Posted by druthomas on Tuesday 16 February, 2010 01:19 PM
A decade of transformation in cataract surgery expands options for a more informed population of cataract patients, while altering surgeon/patient interaction about the procedure.
Click to read Cataract Surgery—A Decade of Change»
Posted by wfreeman on Tuesday 16 February, 2010 01:19 PM
This month's news includes the latest from Staar Surgical, SurModics, and Thrombogenics, plus dates and locations for a selection of upcoming 2010 ophthalmic meetings.
Click to read February 2010 News Briefs»
Posted by All on Tuesday 16 February, 2010 01:19 PM
In 2009, the recession-induced decline in demand for refractive surgery was particularly hard felt in the US where many refractive surgeons shifted clinical emphasis and scores of corporate laser centers closed.
Click to read Global Recession Shadows 2009 Refractive Market»
Posted by daveanddru on Tuesday 19 January, 2010 03:04 PM
In 2009, premium IOL technology drove market growth in the IOL industry, while the promise of investigational femtosecond laser-assisted cataract surgery (FLASC) devices captured the interest of many IOL surgeons.
Click to read Premium Lenses Drove IOL Market Growth in 2009»
Posted by wfreeman on Tuesday 19 January, 2010 03:04 PM
In 2009, the much-awaited CATT study of Lucentis and Avastin moved forward, VEGF Trap drew attention in the crowded retinal pipeline, and dry AMD was christened the new frontier for retinal medicine. Vitreoretinal surgeons also made a decisive turn to micro-incision procedures.
Click to read 2009 Highlights in AMD Pharma & Retinal Surgery»
Posted by William Freeman and Dru Thomas on Tuesday 19 January, 2010 03:04 PM
Bausch & Lomb has launched the new Crystalens AO with a prolate aspheric optic, increasing the options within the only accommodating IOL family commercially available in the US.
Click to read Crystalens AO is Launched»
Posted by wfreeman on Tuesday 19 January, 2010 03:04 PM
Novartis has taken additional steps in its purchase of Alcon, as Alcon’s minority shareholders protest the proposed exchange value.
Click to read Novartis Makes Important Steps in Alcon Acquisition»
Posted by daveanddru on Tuesday 19 January, 2010 03:04 PM
Seven ophthalmic pharmaceuticals gained FDA regulatory approval during 2009.
Click to read New Ophthalmic Drugs Enter the US Market in 2009»
Posted by druthomas on Tuesday 19 January, 2010 03:04 PM
Five ophthalmic devices gained FDA regulatory approval during 2009.
Click to read New Ophthalmic Devices Enter the US Market in 2009»
Posted by David Harmon and William Freeman on Tuesday 19 January, 2010 03:04 PM
This month's news includes the latest from Safilens, Ziemer Group, EyeGate Pharma, TLC Vision, LCA-Vision/LASIKPlus and SK3 Group .
Click to read January 2010 News Briefs»
Posted by All on Tuesday 19 January, 2010 03:04 PM
Manufacturers representatives are often an effective way to gain quick market exposure for a product, but these relationships often lead to significant problems as marketing strategies evolve. Recent court decisions against Staar Surgical highlight some of these pitfalls.
Click to read Manufacturers and Independent Reps: A Complicated Relationship»
Posted by wfreeman on Tuesday 29 December, 2009 04:14 PM
Click to read Independent Rep Wins Judgment Against Staar Surgical »
Posted by wfreeman on Tuesday 29 December, 2009 04:14 PM
Alcon announced plans to enter the glaucoma surgical device market through the acquisition of Optonol and its Ex-PRESS Mini Glaucoma Shunt.
Click to read Alcon to Enter Glaucoma Surgical Market by Acquiring Optonol»
Posted by daveanddru on Tuesday 29 December, 2009 04:14 PM
Several new strategic acquisitions and collaborations are preparing Alcon for a more active role in ophthalmic biotech and the market opportunity it promises.
Click to read Alcon Makes Strategic Moves in Ophthalmic Biotech»
Posted by druthomas on Tuesday 29 December, 2009 04:14 PM
Following two years of serious economic woes, we expect the global refractive surgery market to begin to slowly recover in 2010, as economic growth returns to the US and other wealthy markets. With an improving global economy, refractive surgeries are also expected to increase in emerging markets.
Click to read Slow Recovery Expected in Global Refractive Market»
Posted by daveanddru on Tuesday 29 December, 2009 04:14 PM
This month's news includes the latest from Abbot Medical Optics, Regeneron, Sanofi-Aventis, Fovea Pharmaceuticals, and Bausch and Lomb.
Click to read December 2009 News Briefs»
Posted by All on Tuesday 29 December, 2009 04:14 PM
Q3-2009 refractive surgery volume is down 15 percent from Q3-2008 during this punishing economic downturn, but there are signs an upturn may begin in Q1-2010.
Click to read Q3-2009 US Refractive Surgery Down 15 Percent »
Posted by daveanddru on Monday 16 November, 2009 05:50 PM
The rate of growth of IOL procedure volume has slowed in Q3-2009, but we expect it to rise to 3 percent again in 2010, echoing the growth rate in the US senior population.
Click to read Q3-2009 US IOL Procedures Up 1.8 Percent»
Posted by daveanddru on Monday 16 November, 2009 05:50 PM
The 2009 joint meeting of the AAO and PAAO in San Francisco drew a larger crowd than in 2008 with a significant increase in physicians from outside the US. The agenda featured a rich diversity of ophthalmological issues and technologies.
Click to read AAO/PAAO Meeting in San Francisco Draws a Crowd»
Posted by All on Monday 16 November, 2009 05:50 PM
- PC-IOLs
- Treatments for Astigmatic Cataract Patients
- Tools for Post-op Refractive Accuracy
- Cataract Removal Equipment
Click to read AAO/PAAO Meeting - IOLs and Cataract Surgery »
Posted by wfreeman on Monday 16 November, 2009 05:50 PM
- Excimer Lasers
- Femtosecond Lasers
- Corneal Inlays
- Collagen Crosslinking
Click to read AAO/PAAO Meeting - Refractive Surgery Technology»
Posted by daveanddru on Monday 16 November, 2009 05:50 PM